Cumulative effects of irreversible MAO inhibitors in vivo
- 1 April 1979
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 28 (7), 995-1002
- https://doi.org/10.1016/0006-2952(79)90293-4
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Deprenil: loss of selectivity for inhibition of B-type MAO after repeated treatmentBiochemical Pharmacology, 1978
- Monoamine oxidase A and B: A useful concept?Biochemical Pharmacology, 1978
- A model for the selective mode of action of the irreversible monoamine oxidase inhibitors clorgyline and deprenyl, based on studies of their ability to activate a Ca2+-Mg2+ ATPase in defined lipid environmentsJournal of Pharmacy and Pharmacology, 1977
- Substrate-selective inhibition of monoamine oxidase by some cyclopropylamino substituted oxadiazolesBiochemical Pharmacology, 1976
- Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugsLife Sciences, 1974
- AUotopic Properties of Human Brain Monoamine OxidaseNature New Biology, 1973
- Rates of recovery of irreversibly inhibited monoamine oxidases: A measure of enzyme protein turnoverNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1972
- MONOAMINE OXIDASE: AN APPROXIMATION OF TURNOVER RATESJournal of Neurochemistry, 1971
- Some observations upon a new inhibitor of monoamine oxidase in brain tissueBiochemical Pharmacology, 1968
- A sensitive and specific assay for the estimation of monoamine oxidaseBiochemical Pharmacology, 1963